Komori
Share Issuance and Disposal4565Nxera Pharma Co.,Ltd.Pharmaceuticals

Notice of Partial Forfeiture under the RSU Plan (Decrease in Number of Shares to Be Issued, etc.)

The issuance of new shares under the RSU (restricted stock unit) plan has been completed. Due to the forfeiture of awards by 4 eligible persons, the number of shares issued decreased from the initially planned 736,190 shares to 729,558 shares. Accordingly, the total issue price and the number of allottees also decreased.

Worth reading
38Recurring
Scored from 4 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
6632
Decrease in shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Issuance of new shares under the RSU plan

Who receives how much729,558Shares

736,190 shares before → 729,558 shares after

Lapsed portion6,632 shares
18th RSU: 2 directors and executive officers of the Company, directors of subsidiaries, and 143 employees of the Company and its subsidiaries208,483 shares
20th RSU: 3 directors and executive officers of the Company, directors of subsidiaries, and 203 employees of the Company and its subsidiaries521,075 shares

The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.

RSU No. 18 ¥1,011 per share / RSU No. 20 ¥1,011 per share
Total issue value

RSU No. 18 ¥210,776,313 / RSU No. 20 ¥526,806,825

Categories and Number of Persons Covered
RSU No. 18 2 directors and executive officers of the Company, directors of subsidiaries, and 143 employees of the Company and its subsidiaries / RSU No. 20 3 directors and executive officers of the Company, directors of subsidiaries, and 203 employees of the Company and its subsidiaries
Payment date
18 May 2026
Procedures under the Corporate Code of Conduct
A securities registration statement has been filed under the Financial Instruments and Exchange Act.
Details of issuance or disposal
ItemDetails
Type of issuance or disposalIssuance of new shares under the RSU plan
Number of shares to be issued or disposed of736,190 common shares of the Company (18th RSU: 208,977 shares; 20th RSU: 527,213 shares) → 729,558 common shares of the Company (18th RSU: 208,483 shares; 20th RSU: 521,075 shares)
Issue price and disposal priceRSU No. 18 ¥1,011 per share / RSU No. 20 ¥1,011 per share
Total issue valueRSU No. 18 ¥210,776,313 / RSU No. 20 ¥526,806,825
Payment date18 May 2026
Intended allotteeCategory 18th RSU: 2 directors and executive officers of the Company, directors of subsidiaries, and 143 employees of the Company and its subsidiaries / Number of Shares 208,483 shares, Category 20th RSU: 3 directors and executive officers of the Company, directors of subsidiaries, and 203 employees of the Company and its subsidiaries / Number of Shares 521,075 shares
Categories and Number of Persons CoveredRSU No. 18 2 directors and executive officers of the Company, directors of subsidiaries, and 143 employees of the Company and its subsidiaries / RSU No. 20 3 directors and executive officers of the Company, directors of subsidiaries, and 203 employees of the Company and its subsidiaries
Procedures under the Corporate Code of ConductA securities registration statement has been filed under the Financial Instruments and Exchange Act.
Items this document does not state (20)
Amount of funds to be raisedEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise priceExercise periodNumber of Stock Acquisition RightsTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because a total of 4 of the persons scheduled to receive allotments when the issuance of new shares was decided forfeited their awards.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Partial Forfeiture under the RSU Plan (Decrease in Number of Shares to Be Issued, etc.) | Nxera Pharma Co.,Ltd. (4565) timely disclosure | Komori